(Q35112437)

6 August 2017

1 reference

title

North American prophylaxis studies for persons with severe haemophilia: background, rationale and design (English)

1 reference

6 August 2017

0 references

2

Blanchette VS

1 reference

6 August 2017

M. J. Manco-Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709037

26 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12709037

26 December 2023

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2516.9.s1.15.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2516.9.s1.15.x

26 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

26 December 2023

1 reference

6 August 2017

volume

9 Suppl 1

1 reference

6 August 2017

page(s)

44-8; discussion 49

1 reference

Current treatment of hemophilic arthropathy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

The effect of bleeding patterns on the response of haemophilic haemarthroses to different doses of factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

Types of bleeding seen during the first 30 months of life in children with severe haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

Joint evaluation instruments for children and adults with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.15.X

Hemophilia. A new approach to an old disease.

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Musculoskeletal complications of haemophilia: the joint

26 December 2023

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

The destructive capabilities of the synovium in the haemophilic joint

26 December 2023

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study

26 December 2023

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Utility of magnetic resonance imaging for management of hemophilic arthropathy in children

26 December 2023

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group

26 December 2023

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Results of secondary prophylaxis in children with severe hemophilia

26 December 2023

14

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients

26 December 2023

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

A long-term study of hemophilic arthropathy of the knee joint on a program of Factor VIII replacement given at time of each hemarthrosis

26 December 2023

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Haemophilia in Sweden VII. Incidence, Treatment and Prophylaxis of Arthropathy and other Musculo-Skeletal Manifestations of Haemophilia A and B

26 December 2023

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Prophylactic therapy in classical hemophilia: a preliminary report

26 December 2023

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Experimental Prophylaxis of Severe Hemophilia With a Factor VIII Concentrate

26 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Prophylaxis of joint hemorrhages in hemophilia

26 December 2023

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

26 December 2023

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

Prophylaxis with Factor Concentrates in Preventing Hemophilic Arthropathy

26 December 2023

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.15.X

26 December 2023

Identifiers

1 reference

6 August 2017

1 reference